ArticleJournal of translational medicine2023

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors.

Dong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.